This specialty practice discussion group is intended for nurse educator members of APHON. Remember... View more
This specialty practice discussion group is intended for nurse educator members of APHON. Remember that anything published in this community can be seen by any member of the community. Please be considerate of the HIPAA Privacy Rule when posting to the community.
Are you sure you want to leave ?
Reply To: PPE for MTX administration to non-oncology patients
We are currently putting together education to be disseminated to all nurses in the system on PPE, our closed system transfer device (CSTD) and protection from hazardous medications. Currently, we do have a system hazardous medication policy that outlines PPE use for all hazardous medications (included is all doses of MTX) and all of our hazardous medications do have a label that indicates hazard and which PPE may be included (however, I cannot validate the compliance with hazardous medication PPE outside of oncology)
As an aside, we are only utilizing our Closed System Transfer Device (OnGuard- BBraun) for hazardous oncology meds since the non-oncology nurses have not received the education; however, after the education is given to all nurses, the CSTD use will expand to hazardous medications provided even outside the oncology patients.
—————————— Kimberly Duback, MS, APN, PCNS-BC, CPN, CPHON Advanced Practice Nurse Advocate Children’s Hospital Illinois United States of America —————————— ——————————————- Original Message: Sent: 05-23-2018 02:48 PM From: Dina Smith Schnurman Subject: PPE for MTX administration to non-oncology patients
Does your institution require nurses to wear PPE for administration of MTX to rheumatology patients? We have this set as our standard but are receiving push back from rheumatology because it is a low dose of MTX. The MTX is not always available in the injection pens, so they are requesting nursing teach families how to draw up MTX from a vial- not under a hood, and without PPE. Would like some feedback from other institutions who administer MTX to rheumatology patients.
—————————— Dina Smith Schnurman, CPON,MBA,MSN,RN Sidra Medicine Doha, Qatar ——————————